Natural products remain a cornerstone in the discovery of bioactive compounds with potent anticancer properties.
Xantolis cambodiana, despite its traditional use in Southeast Asian medicine for inflammatory conditions, has remained scientifically underexplored regarding its oncological applications. This study demonstrates that
X. cambodiana extracts effectively suppress A549 lung cancer cell progression through a multifaceted mechanism involving growth inhibition, antimigratory activity, and induction of PCD through ROS-mediated mitochondrial pathways (
17,
18).
A primary requirement for a viable anticancer candidate is selective cytotoxicity. Our results established a favorable therapeutic window, as the extracts targeted A549 cells at concentrations significantly lower than those affecting normal NHDF cells. Although normal cells were tested up to 250 µg/mL, their high viability, 2.5- to 3-fold higher than the IC₅₀ of the active fractions, provides evidence of selectivity. This suggests that
X. cambodiana phytochemicals specifically exploit the unique metabolic vulnerabilities of cancer cells, such as their heightened sensitivity to oxidative stress, while sparing healthy fibroblastic cells within the effective pharmacological range (
18).
A critical finding in our study was the kinetic divergence between short-term apoptotic induction at 24 hours and long-term cytotoxicity at 72 hours. Although the methanol extract was the most efficient at triggering late apoptosis within 24 hours, the hexane extract exhibited the highest cumulative potency at 72 hours. This “disconnect” is likely attributable to the distinct chemical nature of polar versus nonpolar constituents. Nonpolar compounds in the hexane fraction may induce a gradual, sustained cytotoxic effect involving cell cycle arrest or early-stage apoptosis that fully manifests as reduced cell mass over a longer duration. Conversely, polar compounds in the methanol extract appear to initiate a more rapid apoptotic cascade. This highlights that IC₅₀ values reflect a cumulative inhibitory impact, whereas flow cytometry provides specific temporal insights into the mode of cell death (
19,
20).
The observed antimigratory activity, particularly in the distilled water and methanol extracts, suggests that
X. cambodiana may interfere with the machinery of metastasis. Metastasis is a complex process in which malignant cells disseminate and establish secondary tumors (
21). In lung cancer, this process is often facilitated by matrix metalloproteinases (MMPs), such as MMP-9, which degrade the extracellular matrix (
22,
23). Similar to other Thai medicinal plants, such as
Centella asiatica and
Cratoxylum formosum, which inhibit migration by downregulating MMP expression (
24,
25), extracts of
X. cambodiana warrant further investigation to determine whether they specifically target the MMP-9 pathway or cytoskeletal remodeling.
The interplay between apoptosis and autophagy is pivotal in determining cancer cell fate. Our data showed that
X. cambodiana induced late apoptosis and significantly enhanced autophagy, with the ethyl acetate fraction showing the most robust autophagic induction. Autophagy often involves the conversion of LC3-I to LC3-II and regulation of Beclin-1 (
26,
27). Similar to curcumin and S-saponin, which trigger autophagy in A549 cells (
28,
29), our extracts likely modulate these autophagic markers. Although the current study serves as a preliminary screening, the observed crosstalk between these PCD pathways is consistent with findings in other potent medicinal plants, such as Piper nigrum and Poria cocos, which engage both intrinsic and extrinsic apoptotic signaling (
19,
25).
Finally, our results identify ROS-mediated mitochondrial dysfunction as a central mechanistic driver. The significant correlation between ROS accumulation and loss of mitochondrial membrane potential suggests that the extracts trigger the opening of mitochondrial permeability transition pores, leading to the release of proapoptotic factors into the cytosol (
30). However, this study has certain limitations that should be addressed in future research. First, although the JC-1 assay clearly demonstrated a decrease in ΔΨm relative to the control, the absence of a standard positive control, such as carbonyl cyanide m-chlorophenyl hydrazone (CCCP), for mitochondrial depolarization is noted. Second, although the dose-dependent relationship between oxidative stress and mitochondrial damage strongly indicates a ROS-dependent mechanism, antioxidant rescue experiments, such as those using N-acetylcysteine, were not performed in this initial screening to confirm absolute causality (
31,
32).
Furthermore, although our functional assays, including flow cytometry and staining, provide strong evidence for the induction of apoptosis and autophagy, the direct mechanistic links at the molecular level remain to be fully established. Key molecular markers, such as caspase activation, the Bax/Bcl-2 ratio, and the expression of LC3-II or Beclin-1, were not investigated by Western blot analysis in this preliminary study. Future research using specific ROS scavengers and protein-level quantification will be essential to definitively map the signaling pathways and molecular targets of X. cambodiana-induced cell death. Despite these limitations, the current findings provide an important foundation for the development of X. cambodiana as a promising plant-derived candidate for lung cancer treatment.
5.1. Conclusions
In conclusion, this study demonstrates the significant antitumor potential of X. cambodiana against A549 lung cancer cells, characterized by selective cytotoxicity that spares normal NHDF cells. Our findings establish that the extracts suppress cancer cell proliferation and migration through robust induction of ROS-mediated apoptosis and mitochondrial dysfunction. The observed kinetic differences in death signaling between polar and nonpolar fractions suggest that diverse phytochemicals in X. cambodiana contribute to its efficacy. These results identify X. cambodiana as a promising candidate for targeted lung cancer therapy and warrant further bioassay-guided isolation of active compounds and in vivo validation for preclinical development.